A panel of federal judges is set to hear arguments regarding the abortion drug mifepristone. The hearing will focus on whether prescribing rules for the drug should be tightened. This includes considering restrictions on access to abortion pills via telehealth subscriptions.

Further details about the hearing and the potential implications of tightened prescribing rules are available. The case involves the consideration of new restrictions on access to mifepristone. The hearing is expected to address the issue of prescribing rules for the abortion drug, with a panel of federal judges set to hear arguments on the matter.